The Asia Pacific vaccine market is experiencing significant growth, reflecting the region’s proactive stance toward combating infectious diseases. In 2023, the market was valued at USD 4.56 billion, driven by innovative vaccine technologies and expanding immunization initiatives. With a projected CAGR of 7.8%, the market is anticipated to reach nearly USD 8.95 billion by 2032. […]
